Bystander T Cells: A Balancing Act of Friends and Foes
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
T cell responses are essential for appropriate protection against pathogens. T cell immunity is achieved through the ability to discriminate between foreign and selfmolecules, which relies heavily on stringent T cell receptor (TCR) specificity. Recently, bystander activated T lymphocytes, specific for unrelated epitopes during an antigen-specific response, have been implicated in various diseases. Numerous infection models have challenged the classic dogma of T cell activation as solely dependent on TCR and major histocompatibility complex (MHC) interactions, indicating an unappreciated role for pathogen-associated receptors on T cells. Here, we discuss specific roles of bystander activated T cells in pathogenesis, shedding light on the ability of these cells to modulate disease severity independently from TCR recognition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates
Simoni, Y., Becht, E., Fehlings, M., Loh, C. Y., Koo, S.-L., Teng, K. W. W., Yeong, J. P. S., Nahar, R., Zhang, T., Kared, H., et al. (2018) · Nature · doi:10.1038/s41586-018-0130-2 · Cited by 1,370
Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations
Seidel, J. A., Otsuka, A., & Kabashima, K. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00086 · Cited by 1,360 · cited 1×
“Another relatively successful therapeutic intervention includes the use of neutralizing antibodies targeting immune checkpoints CTLA-4 and PD-1 for certain tumors[108].”
BackgroundThe multiple pathways to autoimmunity
Theofilopoulos, A. N., Kono, D. H., & Baccala, R. (2017) · Nature Immunology · doi:10.1038/ni.3731 · Cited by 590
Miethke, T., Wahl, C., Heeg, K., Echtenacher, B., Krammer, P. H., & Wagner, H. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.1.91 · Cited by 574
Cytokines in Cancer Immunotherapy
Waldmann, T. A. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028472 · Cited by 507
Atkinson, M. A., Bowman, M. A., Campbell, L., Darrow, B. L., Kaufman, D. L., & Maclaren, N. K. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117567 · Cited by 448
Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy
Vesely, M. D., & Schreiber, R. D. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12105 · Cited by 367 · cited 1×
“Patients and tumors respond variably to immunotherapy, which is attributed in part, to the diversity of the immune repertoires, heterogeneity of the tumor-infiltrating lymphocytes (TILs) and the complexity of the tumor itself [5, 98].”
BackgroundWeng, N.-P., Araki, Y., & Subedi, K. (2012) · Nature Reviews Immunology · doi:10.1038/nri3173 · Cited by 290 · cited 1×
“Memory T cells are more sensitive to cytokine-mediated signals than antigeninexperienced T cells, and can be triggered to release their cytotoxic contents when exposed to far lower cytokine concentrations than naïve T cells [82, 83].”
BackgroundCytotoxic mAb from rheumatic carditis recognizes heart valves and laminin
Galvin, J. E., Hemric, M. E., Ward, K., & Cunningham, M. W. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7132 · Cited by 248
White, J. T., Cross, E. W., Burchill, M. A., Danhorn, T., McCarter, M. D., Rosen, H. R., O’Connor, B., & Kedl, R. M. (2016) · Nature Communications · doi:10.1038/ncomms11291 · Cited by 219
Cited by
Multiple early factors anticipate post-acute COVID-19 sequelae
Su, Y., Yuan, D., Chen, D. G., Ng, R. H., Wang, K., Choi, J., Li, S., Hong, S., Zhang, R., Xie, J., et al. (2022) · Cell · doi:10.1016/j.cell.2022.01.014 · Cited by 1,156
“CMV-specific T cell bystander activation associates with GI PASC Bystander activation describes the case when T lymphocytes with specificities for unrelated epitopes are activated during an antigen-specific response (Whiteside et al., 2018).”
The activation of bystander CD8+ T cells and their roles in viral infection
Kim, T.-S., & Shin, E.-C. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0316-1 · Cited by 187
Gamma delta T-cell-based immune checkpoint therapy: attractive candidate for antitumor treatment
Gao, Z., Bai, Y., Lin, A., Jiang, A., Zhou, C., Cheng, Q., Liu, Z., Chen, X., Zhang, J., & Luo, P. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01722-0 · Cited by 138
Significance of bystander T cell activation in microbial infection
Lee, H., Jeong, S., & Shin, E.-C. (2022) · Nature Immunology · doi:10.1038/s41590-021-00985-3 · Cited by 134
CXCR3 enables recruitment and site-specific bystander activation of memory CD8(+) T cells
Maurice, N. J., McElrath, M. J., Andersen-Nissen, E., Frahm, N., & Prlic, M. (2019) · Nature Communications · doi:10.1038/s41467-019-12980-2 · Cited by 117
Metadata
- Authors
- Whiteside, S. K., Snook, J. P., Williams, M. A., & Weis, J. J.
- Venue
- Trends in Immunology
- Publisher
- Elsevier BV
- Published
- 2018-12
- Volume
- 39
- Issue
- 12
- Pages
- 1021-1035
- ISSN
- 1471-4906 (ISSN-L)
- OpenAlex
- W2899702946
- Cited by
- 106
- References
- 12
- FWCI
- 0.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bystander T Cells: A Balancing Act of Friends and Foes. https://app.cochat.ai/papers/10.1016/j.it.2018.10.003
- The paper
- Whiteside, S. K., Snook, J. P., Williams, M. A., & Weis, J. J. (2018). Bystander T Cells: A Balancing Act of Friends and Foes. Trends in Immunology. https://doi.org/10.1016/j.it.2018.10.003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.